Actually try to imagine that alliances/mergers make a stronger whole. With that, Pharmacia has acknowledged that PDGM can produce what they need in the sequencing arena <and then some>. So, the Cereon issues you speak of most definitely enhance Pardigm Genetic's position in providing for a plethora of patented plant sequences (don't forget about the resulting human anitfungals).
Do not be fooled - Monsanto/Pharmacia will not be "out of the business" and are by no means turning away from anything; They are simply employing Paradigm's ability to better provide Pharmacia with the techologies and output above what could have been realized by an internal effort with Cereon.
Albeit there is somewhat of a "backlash" against plant genomics now, truth be told that politicians and humankind alike cannot argue that the Earth's climate /environment is changing faster than our plants can adapt. That shall prove the ultimate charge for plant genomics, and in particular, the deserved importance and value of Paradigm Genetics. Pharmacia isn't the only company signed on!
I too enjoyed a similar fate with INSP. I would certainly equate the potential here with PDGM to that of INSP (actually more % here). Any of you doing DD can realize the global and humankind implications of PDGM, even sooner than those to be experienced by CRA.
The companies on board now and those already knocking on the door should far excede the competition from EXEL. I would settle that EXEL's currrent price is relative to their stronger balance sheet from last quarter. This will certainly change as PDGM sounds to have more ammo stores yet to be fired and will continue to grow exponentially in its global reach, highly skilled scientists, and long-term patners by Q4-2000. More PR and announcements would be nice to that affect <come on PDGM>.
Let's face it though, even with what is already announced - wheat and rice are staple food crops around the world. With Bayer alone amidst a genetic Paradigm shift <sorry>, the pesticides and crop protection they produce now will eventually be replaced with stronger seeds and sequences patented by PDGM.
This isn't just a ride, this is the future for humankind. Particularly considering that our plants cannot adjust naturally to the environment as quickly as the Earth's inhabitants are changing it.
This company is HUGE - from cereal to the milk we pour over it, PDGM is going to touch it!
PDGM should prove to not only be pulling the freight train that IS plant genomic discovery but they are laying the track for the entire future of plants in our rapidly changing environment. From their recent accomplishments for two of the world's largest food crops (wheat and rice), to the plethera of deals and mappings we've only heard rumblings of ...$20 is extremely reserved for the global reach this company is only beginning to unveil.
CRA and the like are making monumental strides to better our lives from their human genomic efforts. However, the realization that we as humankind must preserve/strengthen the Earth's plant life in order to better plant survival within our changing climates, appears to have taken a back seat. The importance of strengthening world food crops will be more immediatly beneficial when considering that if our plant life dies off, so do we; One could even argue an extreme that without strengthened crops we may not make it to realize the human genome efforts if harsher climates continue to threaten our food belts. The heck with high fuel prices!
DD on PDGM looks VERY promising for the future. I would expect the numerous benefits to be realized by such things as reduced land useage for world farmers to produce increased crops, or the enablement to better feed famished nations. Moreover, the correllating profits that the leading edge technologies Paradigm Genetics will increaingly provide the world as seen in the growing profits and global alliances.
I would expect these profits to be rolling in more immediately than that expected <yet inevitable> from CRA and the like. Be it to eliminate the need for pestisides, or such that wheat and/or rice crops can florish during droughts in mid-US to Africa, PDGM's patented efforts should yeild a better life for our world and its inhabitants as a whole.
This is not to say that the human genome efforts are for not. Just that given the politics and privacy issues (even the decades that an accurate human map will take to be applied for market insertion), plant genomics and the companies that already employ PDGM's leading technologies (and those which sign-on in the future) will all be able to revel in the numerous accomplishments around the world in the more near term.
This seems like the proverbial tip of the iceberg for PDGM. With many of these recent ratings and picks (JP Morgan,CNBC...), this one should soon see the attention it deserves and blow through those targets many times over!